CONWAY, S.C., Nov. 20, 2017 /Weed Wire/ — One of America’s leading cannabidiol companies has received approval to air the nation’s first cannabis-based product advertising. Ads for Palmetto Harmony begin airing Monday on several national networks, including but not limited to: Oxygen, Lifetime Movies, WE, FYI, BBC-America, Centric, Freeform, GAC, UP, and 71 local market affiliates for ABC, NBC, CBS, and Fox.
Tag Archives: Cannabidiol
People who buy medical marijuana online may not necessarily get exactly what they expect when their package arrives in the mail, new research suggests.
A new Indiana law that allows people with certain types of epilepsy to use a marijuana-derived oil for treatment has spurred a statewide crackdown, making it more difficult for those seeking the product to obtain it.
Gov. Kim Reynolds named eight Iowans Wednesday to serve on a state board that will oversee the state’s expanded medical cannabis law.
As more states legalize adult use marijuana, hemp CBD makers will find that they will need to make marijuana-derived products too if they want to succeed.
Clinical-stage cannabinoid-based drug developer Zynerba Pharmaceuticals (NASDAQ:ZYNE) had been one of the strongest-performing pot stocks over the trailing year prior to the start of this past week.
Zynerba Pharmaceuticals Inc said on Monday its synthetic cannabis-based gel to treat epilepsy failed a mid-stage study, sending the U.S. drug developer’s shares plunging 50 percent.
On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.
A new cannabis study published in the New England Journal of Medicine saw a nearly 40 percent drop in seizures for participants who were using the marijuana derivative called cannabidiol.
WASHINGTON, May 25, 2017 /Weed Wire/ — Senators Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), leaders of the Senate Caucus on International Narcotics Control, today introduced the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.
GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.
NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.
SYDNEY, Australia, May 24, 2017 /Weed Wire/ — The Hydroponics Company Limited (ASX:THC) (“THC” or “the Company”) is pleased to announce that it has signed an exclusive Strategic Alliance with Colorado-based healthcare solutions company Phoenix Life Sciences Inc (“Phoenix Life”) to collaboratively research, develop, manufacture, distribute and sell medicinal cannabis products in Australia and internationally.
WASHINGTON, May 1, 2017 /Weed Wire/ – Continuing his fight to help families with children suffering from debilitating forms of epilepsy, Congressman Scott Perry joined with Senator Corey Gardner (R-CO) to reintroduce the Charlotte’s Web Medical Access Act of 2017.
On April 17, 2017, Wisconsin Gov. Scott Walker signed Senate Bill 10, legalizing possession of cannabidiol oil for those patients who have been certified by their physicians to use it.
DENVER, April 6, 2017 /Weed Wire/ — Ubiquitech Software Corp. (OTC PINK: UBQU), through its subsidiary HempLife Today, an innovative and growing Company offering the finest CBD (Cannabidiol) products derived from Hemp, is announcing that it is giving away a free trial pack of six (6) CannazALL™ CBD GelCaps to all existing shareholders, their families and friends.
DEVON, Penn., March 13, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has completed enrollment in the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 cannabidiol (CBD) gel in adult epilepsy patients with refractory focal seizures.
Insys Therapeutics announced a compassionate-use program for its cannabis-based epilepsy drug, igniting optimism that the company is continuing to develop marijuana medicine.
On Feb. 21, 2017, the Iowa House Public Safety Committee voted to advance HSB 132, a bill that would slightly expand the state’s limited medical marijuana program and leave room for further expansion down the road.
WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”
The Georgia Senate has passed a bill that would require a reduction in the amount of THC in cannabis oil. Senate Bill 16 reduces the amount of THC, the psychoactive chemical in marijuana, allowed in cannabis oil from 5 percent to 3 percent. However, the bill also adds a medical condition, autism, to the eight legal uses of medical marijuana established in 2015.
Could cannabis-infused chewing gum be a potential solution for IBS sufferers? The Doctors discuss a new medical trial in the Netherlands with promising results.
A justice on the Brazilian Supreme Court has called for the legalization of marijuana and even harder drugs as a means to ending violence among drug gangs, according to a Feb. 10, 2017, article from Reuters. The justice, Roberto Barroso, is a constitutional law professor who was educated at Yale University in the United States.
ANCHORAGE, Feb. 9, 2017 /Weed Wire/ — Today, enforcement officers of the Alcohol and Marijuana Enforcement Office seized items from several retail stores across the state containing CBD (cannabidiol) oil that appear to be offered for sale in violation of several provisions of AS 17.38, including requirements for testing, packaging, and labeling.
Wisconsin’s state Senate has overwhelmingly approved a bill that would make it legal to use a marijuana extract to treat seizures.
“Cannabis in Parkinson’s Disease: Growing Like a Weed!” was presented at the University of Colorado School of Medicine’s Neurology Grand Rounds on Jan. 18, 2017.
SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.
The father of a first-grade student in Aberdeen, Washington, could become the catalyst for a change in state law that would allow CBD oil at public schools. River Barclay, 7, needs CBD oil to manage a rare form of epilepsy, but state law will not allow her father to go to the school to administer the dose because medical marijuana is illegal on school property.
On Jan. 16, 2017, the Denver-based law firm Hoban Law Group, which represents several clients in the hemp industry, announced that it had filed a petition with the United States Court of Appeals for the Ninth Circuit to challenge a new DEA rule that would make cannabidiol illegal.
Some Wisconsin Republicans who have been opposed to medical marijuana are now warming to the idea of legalizing cannabidiol or CBD oil, according to an article by the Associated Press. Republican state Sen. Van Wanggaard said he wants to introduce a bill allowing possession and use of CBD oil, which has proven to help people with seizures.
Serra Frank was protesting in Boise, Idaho, with Idaho Moms for Marijuana during the second annual New Year’s Smoke Out Protest on Jan. 1, 2016. At 4:20 p.m., she was cited for misdemeanor possession of a controlled substance and possession of paraphernalia, and gave her marijuana to the police, according to Jan. 1, 2016 articles in local media.
On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more cannabinoids are now considered a schedule I substance.
DENVER, Dec. 15, 2016 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement on the recent reports of the United States Drug Enforcement Administration’s rescheduling of all marijuana extracts, including CBD oil as Schedule I controlled substances.
Tennessee Titans linebacker Derrick Morgan is the only active NFL player calling on the league to investigate the merits of cannabidiol, or CBD oil, according to a report at CBSNews.com. Morgan has not used CBD oil, a non-psychoactive chemical from marijuana, because he does not want to risk violating NFL rules on substance abuse.
On Nov. 23, 2016, Canopy Growth Corporation (TSX:CGC) announced that Bedrocan Canada, one of its subsidiaries, had completed its first export of cannabis to South America, shipping 10 kg of dried cannabis to Brazil for the research and development of cannabis-based therapeutics in the country.
BOULDER, Colo., Oct. 25, 2016 /Weed Wire/ — The Hemp Business Journal (HBJ), the hemp industry’s authority on big data and market intelligence, has released The CBD Report showing cannabidiol as one of the fastest growing market categories in the U.S. hemp and legal marijuana industries with a compound annual growth rate of 59%.
On Oct. 2, 2016, Maureen Leehey, MD, discussed the potential of cannabis in treating Parkinson’s disease at the 3rd Annual Parkinson’s Disease Symposium at the University of Colorado Movement Disorders Center.
An experimental cannabis-derived drug has successfully treated children with severe epilepsy in a third late-stage clinical trial, sending shares in Britain’s GW Pharmaceuticals to a record high on Monday.
DENVER — Former Broncos players are opening up about their fight for the NFL to allow players to use medical marijuana to alleviate and even prevent injuries.
MediPen, a cannabis vaporizer, is being tested by the United Kingdom’s National Health Service, according to an Aug. 15, 2016, article in The Independent. It’s the first time a cannabis-based product has been tested by the NHS.
Leonard Marshall, former defensive end for the New York Giants, has partnered with a small pharmacy chain in New Jersey to make cannabis-based medicines if the state legalizes pot, according to an article in the New York Daily News. Aisha Bhatti, director of pharmacy for Hometowne Rx, said her company is “watching the trends” with legalization.
CALABASAS, Calif., July21, 2016 /Weed Wire/ — CBD Incorporated, a Southern California-based startup, has been formed to capitalize on the exponentially growing cannabis market by focusing on what the company believes to be the most promising compound in cannabis.
California-based Major Hemp, a subsidiary of Sipp Industries, has joined forces with Colorado’s Ute Pass Brewing Co. for the production of a hemp craft beer. A trial run of the craft beer, made with a proprietary recipe including hemp and a Cannabidiol infusion, is slated to be released in Colorado this summer.
On April 21, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced it had received Orphan Drug Designation for cannabidiol in the treatment of Tuberous Sclerosis Complex.
LONDON, March 14, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome.
BELLEVUE, Wash., Feb. 18, 2016 /Weed Wire/ — Today at CannaCon 2016, Bellevue, WA based CannaSafety LLC announced increased production and broad availability of their flagship product CannaRelief™, the “world’s first cannabis antidote™” and first in a family of products.
KELOWNA, British Columbia, Oct. 8, 2015 /Weed Wire/ — Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce that the manufacturing process to infuse active hemp oil utilizing Lexaria’s patent pending technology designed to provide higher bioavailability, has been completed for both coffee and hot chocolate.
SAN DIEGO, Aug. 11, 2015 /Weed Wire/ — AXIM Biotechnologies, Inc. (OTC: AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products – all derived from industrial hemp.
Scientists in Israel continue to establish their work as the leading source of data on medical cannabis. In a combined study conducted primarily by researchers from Hebrew University of Jerusalem and Tel Aviv University, Cannabidiol (CBD) was found to enhance fracture healing.
In Rhode Island, the currently proposed bill, sponsored by Burrillville Democrat Rep. Cale Keable, would legalize the growth and sale of hemp products.